Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CCRN Cross Country Healthcare Inc
$9.38 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CCRN stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 307.9M
Enterprise value 201.3M
Trailing PE 48.28
Forward PE 34
PEG Ratio 0.023744262295082
Enterprise to EBITDA 10.86
Enterprise to revenue 0.191
Price to book MRQ 0.9354427
Price to sales TTM 0.29581413

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 1.1B
EBITDA 43.5M
Diluted EPS TTM -2.93
Total Cash (MRQ) 108.7M
Current ratio (MRQ) 3.776
Operating Cash Flow (TTM) 48.3M

CCRN trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CCRN News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.